The aim of this study is to estimate the diagnostic value of postcontrast susceptibility-weighted imaging (CESWI) in the assessment of intracranial brain neoplasm at 3 T MRI. Our results showed that the SWI can be performed after gadolinium injection without information loss or signal change and the CESWI clearly visualized the characteristics and the architecture of brain neoplasm. The CESWI can be a match to the CET1 with regard to the visibility of tumor margin and internal architecture in intracranial tumors without information loss or signal change.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords